These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 17460285

  • 1. Clearance of intravitreal voriconazole.
    Shen YC, Wang MY, Wang CY, Tsai TC, Tsai HY, Lee YF, Wei LC.
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2238-41. PubMed ID: 17460285
    [Abstract] [Full Text] [Related]

  • 2. Clearance of intravitreal moxifloxacin.
    Iyer MN, He F, Wensel TG, Mieler WF, Benz MS, Holz ER.
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):317-9. PubMed ID: 16384979
    [Abstract] [Full Text] [Related]

  • 3. Comparison of voriconazole concentration in the aqueous humor and vitreous between non-scraped and scraped corneal epithelium groups after topical 1% voriconazole application.
    Wei LC, Tsai TC, Tsai HY, Wang CY, Shen YC.
    Curr Eye Res; 2010 Jul; 35(7):573-9. PubMed ID: 20597643
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of intracameral voriconazole injection.
    Shen YC, Wang MY, Wang CY, Tsai TC, Tsai HY, Lee HN, Wei LC.
    Antimicrob Agents Chemother; 2009 May; 53(5):2156-7. PubMed ID: 19258273
    [Abstract] [Full Text] [Related]

  • 5. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans.
    Hariprasad SM, Mieler WF, Holz ER, Gao H, Kim JE, Chi J, Prince RA.
    Arch Ophthalmol; 2004 Jan; 122(1):42-7. PubMed ID: 14718293
    [Abstract] [Full Text] [Related]

  • 6. Intravitreal clearance of moxifloxacin.
    Iyer MN, He F, Wensel TG, Mieler WF, Benz MS, Holz ER.
    Trans Am Ophthalmol Soc; 2005 Jan; 103():76-81; discussion 81-3. PubMed ID: 17057790
    [Abstract] [Full Text] [Related]

  • 7. Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans.
    Vemulakonda GA, Hariprasad SM, Mieler WF, Prince RA, Shah GK, Van Gelder RN.
    Arch Ophthalmol; 2008 Jan; 126(1):18-22. PubMed ID: 18195213
    [Abstract] [Full Text] [Related]

  • 8. Intraocular concentration of triamcinolone acetonide after intravitreal injection in the rabbit eye.
    Kamppeter BA, Cej A, Jonas JB.
    Ophthalmology; 2008 Aug; 115(8):1372-5. PubMed ID: 18355920
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses.
    Clode AB, Davis JL, Salmon J, Michau TM, Gilger BC.
    Am J Vet Res; 2006 Feb; 67(2):296-301. PubMed ID: 16454636
    [Abstract] [Full Text] [Related]

  • 10. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
    Breit SM, Hariprasad SM, Mieler WF, Shah GK, Mills MD, Grand MG.
    Am J Ophthalmol; 2005 Jan; 139(1):135-40. PubMed ID: 15652837
    [Abstract] [Full Text] [Related]

  • 11. Safety of intravitreal voriconazole: electroretinographic and histopathologic studies.
    Gao H, Pennesi M, Shah K, Qiao X, Hariprasad SM, Mieler WF, Wu SM, Holz ER.
    Trans Am Ophthalmol Soc; 2003 Jan; 101():183-9; discussion 189. PubMed ID: 14971576
    [Abstract] [Full Text] [Related]

  • 12. Clearance of intravitreal daptomycin in uveitis-induced rabbit model.
    Ozcimen M, Sakarya Y, Ozcimen S, Sakarya R, Goktas S, Iyisoy S, Alpfidan I, Erdogan E.
    Curr Eye Res; 2015 May; 40(6):598-603. PubMed ID: 25110947
    [Abstract] [Full Text] [Related]

  • 13. Intravitreal pharmacokinetics and retinal concentrations of ganciclovir and foscarnet after intravitreal administration in rabbits.
    López-Cortés LF, Pastor-Ramos MT, Ruiz-Valderas R, Cordero E, Uceda-Montañés A, Claro-Cala CM, Lucero-Muñoz MJ.
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1024-8. PubMed ID: 11274081
    [Abstract] [Full Text] [Related]

  • 14. Intravitreal voriconazole: in vitro safety-profile for fungal endophthalmitis.
    Kernt M, Neubauer AS, De Kaspar HM, Kampik A.
    Retina; 2009 Mar; 29(3):362-70. PubMed ID: 18997637
    [Abstract] [Full Text] [Related]

  • 15. The pharmacokinetics of rituximab following an intravitreal injection.
    Kim H, Csaky KG, Chan CC, Bungay PM, Lutz RJ, Dedrick RL, Yuan P, Rosenberg J, Grillo-Lopez AJ, Wilson WH, Robinson MR.
    Exp Eye Res; 2006 May; 82(5):760-6. PubMed ID: 16289160
    [Abstract] [Full Text] [Related]

  • 16. [Clearance of liposome-incorporated ciprofloxacin after intravitreal injection in rabbit eyes].
    Wiechens B, Krausse R, Grammer JB, Neumann D, Pleyer U, Duncker GI.
    Klin Monbl Augenheilkd; 1998 Nov; 213(5):284-92. PubMed ID: 9888133
    [Abstract] [Full Text] [Related]

  • 17. Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration.
    Hariprasad SM, Mieler WE, Shah GK, Blinder KJ, Apte RS, Holekamp NM, Thomas MA, Chi J, Prince RA.
    Trans Am Ophthalmol Soc; 2004 Nov; 102():149-55; discussion 155-7. PubMed ID: 15747753
    [Abstract] [Full Text] [Related]

  • 18. Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device.
    Hariprasad SM, Shah GK, Chi J, Prince RA.
    J Cataract Refract Surg; 2005 Nov; 31(11):2142-6. PubMed ID: 16412929
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of voriconazole following intravenous and oral administration and body fluid concentrations of voriconazole following repeated oral administration in horses.
    Colitz CM, Latimer FG, Cheng H, Chan KK, Reed SM, Pennick GJ.
    Am J Vet Res; 2007 Oct; 68(10):1115-21. PubMed ID: 17916020
    [Abstract] [Full Text] [Related]

  • 20. Triamcinolone acetonide concentration of aqueous humor after decanted 20-mg intravitreal injection.
    Cheng L, Banker AS, Martin M, Kozak I, Freeman WR.
    Ophthalmology; 2009 Jul; 116(7):1356-9. PubMed ID: 19450879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.